Sitagliptin triazecine analog
CAS: 2088771-61-1
Ref. 3D-FS180825
| 1g | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Información del producto
Sitagliptin is a pharmaceutical drug that belongs to the group of dipeptidyl peptidase-4 (DPP-4) inhibitors. It is used to lower blood glucose levels in people with type 2 diabetes by increasing insulin release from the pancreas and by reducing the rate of breakdown of glucose-lowering medication. Sitagliptin can be administered orally, as an extended-release tablet or as an injection. It binds to human monocytes and reduces their production of proinflammatory cytokines such as TNF-α and IL-6, which are involved in the pathogenesis of atherosclerosis, diabetes, and obesity. Sitagliptin also has antihyperglycemic effects in animals.
Propiedades químicas
Consulta técnica sobre: 3D-FS180825 Sitagliptin triazecine analog
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
